What Drives Risky Prescription Opioid Use? Evidence from Migration

We thank the National Institute on Aging (Finkelstein R01-AG032449), the National Science Foundation (Williams, 1151497), the Social Security Administration (Finkelstein RDR18000003), and the Stanford Institute for Economic Policy Research (SIEPR) for financial support. We are grateful to Jonathan Gruber, Ellen Meara, David Molitor, Molly Schnell, and seminar participants at the 2021 NBER Summer Institute on Health Economics and the 2022 ASSA Session on the Economics of the Ongoing Opioid Crisis for helpful discussions, and to Alden Cheng, Paul Friedrich, Ken Jung, Geoffrey Kocks, Abby Ostriker, Wesley Price, Anna Russo, and Yuci Zhou for excellent research assistance. The research reported herein was performed pursuant to grant RDR18000003 from the US Social Security Administration (SSA) funded as part of the Retirement and Disability Research Consortium and is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No 214106. The opinions and conclusions expressed are solely those of the author(s) and do not represent the opinions or policy of SSA, any agency of the Federal Government, or NBER. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of the contents of this report. Reference herein to any specific commercial product, process or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply endorsement, recommendation or favoring by the United States Government or any agency thereof. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.